XML 92 R24.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment And Geographic Information
12 Months Ended
Dec. 31, 2019
Segment And Geographic Information [Abstract]  
Segment And Geographic Information 18. Segment and Geographic Information

We have two reportable segments organized according to our products and services: Medical Devices and Preservation Services. The Medical Devices segment includes external revenues from product sales of BioGlue, JOTEC products, On-X products,

CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues. There are no intersegment revenues.

The primary measure of segment performance, as viewed by our management, is segment gross margin, or net external revenues less cost of products and preservation services. We do not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below.

The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands):

2019

2018

2017

Revenues:

Medical devices

$

197,246

$

187,394

$

119,631

Preservation services

78,976

75,447

70,071

Total revenues

276,222

262,841

189,702

Cost of products and preservation services:

Medical devices

55,022

53,772

29,798

Preservation services

38,187

36,085

31,262

Total cost of products and preservation services

93,209

89,857

61,060

Gross margin:

Medical devices

142,224

133,622

89,833

Preservation services

40,789

39,362

38,809

Total gross margin

$

183,013

$

172,984

$

128,642

Net revenues by product for the years ended December 31, 2019, 2018, and 2017 were as follows (in thousands):

2019

2018

2017

Products:

BioGlue

$

68,611

$

66,660

$

65,939

JOTEC

64,974

63,341

4,136

On-X

50,096

44,832

37,041

CardioGenesis cardiac laser therapy

6,016

6,217

6,866

PerClot

3,795

3,767

3,533

PhotoFix

3,754

2,577

2,116

Total products

197,246

187,394

119,631

Preservation services:

Cardiac tissue

40,879

35,683

32,510

Vascular tissue

38,097

39,764

37,561

Total preservation services

78,976

75,447

70,071

Total revenues

$

276,222

$

262,841

$

189,702

Net revenues by geographic location attributed to countries based on the location of the customer for the years ended December 31, 2019, 2018, and 2017 were as follows (in thousands):

2019

2018

2017

U.S.

$

150,553

$

144,651

$

135,102

International

125,669

118,190

54,600

Total revenues

$

276,222

$

262,841

$

189,702

For the years ended December 31, 2019 and 2018, revenues attributed to customers in Germany accounted for 10% of total revenues as a result of the acquisition of JOTEC in December 2017. During December 31, 2017 revenues attributed to customers in any individual country outside the U.S. were 10% or less of total revenues.

At December 31, 2019 and 2018, 57% of our long-lived assets were held in the U.S., where the corporate headquarters and a portion of our manufacturing facilities are located. Our long-lived international assets were $14.1 million as of December 31, 2019, of which 97% were located in Hechingen, Germany. Our long-lived international assets were $13.1 million as of December 31, 2018, of which 98% were located in Hechingen, Germany. At December 31, 2019 and 2018, $186.7 million and $188.8 million, respectively, of our goodwill was allocated entirely to our Medical Devices segment.